Novavax, Inc. (NVAX)

Novavax Revenue

Novavax had revenue of $84.51M in the quarter ending September 30, 2024, a decrease of -54.80%. This brings the company's revenue in the last twelve months to $885.19M, down -15.68% year-over-year. In the year 2023, Novavax had annual revenue of $983.71M, down -50.36%.

• Revenue (ttm): $885.19M
• Revenue Growth: -15.68%
• P/S Ratio: 1.30
• Revenue / Employee: $573,683
• Employees: 1,543
• Market Cap: 1.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	983.71M	-998.17M	-50.36%
Dec 31, 2022	1.98B	835.58M	72.89%
Dec 31, 2021	1.15B	670.69M	141.02%
Dec 31, 2020	475.60M	456.94M	2,448.48%
Dec 31, 2019	18.66M	-15.63M	-45.57%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.